Skip to content

Clinical Evaluation of an Integrated PET/MRI System

Clinical Evaluation of an Integrated PET/MRI System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02071706
Acronym
PET/MR_ZURICH
Enrollment
62
Registered
2014-02-26
Start date
2014-01-31
Completion date
2014-08-31
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects With Clinical Indication for PET/CT

Brief summary

The investigational PET/MRI scanner, including attenuation correction method, is capable of producing diagnostic quality images and appropriate device functionality per user feedback.

Interventions

Enrolled subject undergoes PET/MR scan

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject must have a clinical indication for a PET/CT exam 2. Subject must be at least eighteen (18) years of age; and 3. Female subjects that are determined to be non-pregnant by a physician investigator or are demonstrated non-pregnant by negative urine pregnancy test administered within the 24 hour period before PET/CT imaging; and 4. Subject must be able to hear and understand instructions without assistive devices; and 5. Subject must provide written informed consent; and 6. Subject has the necessary mental capacity to understand instructions, and is able to comply with protocol requirements; and 7. Subject is able to remain still for duration of imaging procedure (approximately 60 minutes total for PET/MRI); and 8. Subject must be able to participate in a PET/MR imaging session within 2 hours of concluding their PET/CT exam and within 4 hours of PET radiotracer administration.

Exclusion criteria

1. Subjects who have any axial diameter larger than 55 cm; or 2. Subjects with a weight greater than 227 kgs; or 3. Subjects that have metallic/conductive or electrically/magnetically active implants without MR Safe or MR Conditional labeling, with the exception of dental devices/fillings, surgical clips, and surgical staples determined to be safe for MRI scanning by a physician investigator; or 4. Subjects that have implants with MR Unsafe labeling; or 5. Subjects that have implants labeled as MR Conditional by the manufacturer for which the allowable conditions are not expected to be achieved by the MR/PET environment or scan protocol ; or 6. Subjects who have a contraindication to MRI according to the screening policy of the participating site

Design outcomes

Primary

MeasureTime frameDescription
Number Usable PET/MRI Image Sets1 dayThe number PET/MRI image sets determined usable by a radiologist on a yes/no binary scale
Number of Diagnostic Quality Images1 dayNumber of images sets deemed diagnostic quality by the investigator

Countries

Switzerland

Participant flow

Recruitment details

First participant enrolled on January 20, 2014. Last participant enrolled on July 07, 2014 at the Zurich University Hospital site. Subject or participant recruitment was prematurely terminated because the sponsor had determined that sufficient data was collected for regulatory submissions

Pre-assignment details

Subjects/participants were enrolled in one of three study segments and received a clinically indicated PET/CT exam with radiopharmaceutical injection followed by PET/MRI scanning. Up to two subject datasets (each dataset labelled with unique subject ID) can be collected from one enrolled participant/subject.

Participants by arm

ArmCount
Single-Arm PET/MRI
Single-group evaluation of PET/MRI for diagnostic quality of image PET/MRI system: Enrolled subject undergoes PET/MR scan
62
Total62

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicSingle-Arm PET/MRI
Age, Customized
Equal to or more than 18 years of age
62 Participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
39 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 62
other
Total, other adverse events
2 / 62
serious
Total, serious adverse events
0 / 62

Outcome results

Primary

Number of Diagnostic Quality Images

Number of images sets deemed diagnostic quality by the investigator

Time frame: 1 day

Population: PET/MR Scans with qualitative comments

ArmMeasureValue (NUMBER)
Single-Arm PET/MRINumber of Diagnostic Quality Images67 Image sets
Primary

Number Usable PET/MRI Image Sets

The number PET/MRI image sets determined usable by a radiologist on a yes/no binary scale

Time frame: 1 day

ArmMeasureValue (NUMBER)
Single-Arm PET/MRINumber Usable PET/MRI Image Sets70 Usable image sets

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026